Literature DB >> 6946465

Subcellular localization and secretion of factor V from human platelets.

C M Chesney, D Pifer, R W Colman.   

Abstract

Factor V, a plasma protein cofactor necessary for optimal conversion of prothrombin to thrombin, is also present in considerable concentration in blood platelets (9.9 units per 10(9) platelets). Subcellular fractionation by two methods has localized factor V in the alpha granules of unstimulated platelets. ADP and epinephrine cause release of 4.6% and 6.4%, respectively, of the total factor V, a process completely inhibited by cyclooxygenase alkylation by aspirin. In contrast, collagen causes release of 25% of platelet factor V, a process only partially suppressed by aspirin. Secretion of factor V depends on the availability of metabolic energy, because antimycin A, an inhibitor of aerobic metabolism, and 2-deoxyglucose, an inhibitor of anaerobic glycolysis, together almost totally inhibited the secretion of factor V induced by collagen. The data establish that factor V is not normally available on unstimulated platelets but can be secreted from alpha granules upon stimulation with physiological agents such as ADP, epinephrine, and collagen. Because factor V is known to serve as a receptor for factor Xa, the exposure of factor V on platelets consequent to release would accelerate the process of blood coagulation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6946465      PMCID: PMC320365          DOI: 10.1073/pnas.78.8.5180

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Interaction of coagulation factor V and factor Va with platelets.

Authors:  P B Tracy; J M Peterson; M E Nesheim; F C McDuffie; K G Mann
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

2.  A simple procedure for separation of prothrombin and accelerator globulin from citrated human plasma.

Authors:  M L LEWIS; A G WARE
Journal:  Proc Soc Exp Biol Med       Date:  1953-12

3.  Distribution of fibrinogen, and platelet factors 4 and XIII in subcellular fractions of human platelets.

Authors:  M J Broekman; R I Handin; P Cohen
Journal:  Br J Haematol       Date:  1975-09       Impact factor: 6.998

4.  Studies on human platelet granules and membranes.

Authors:  A J Marcus; D Zucker-Franklin; L B Safier; H L Ullman
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

5.  Adenine nucleotides and platelet function.

Authors:  H Holmsen; H J Day
Journal:  Ser Haematol       Date:  1971

6.  Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator.

Authors:  B Osterud; S I Rapaport; K K Lavine
Journal:  Blood       Date:  1977-05       Impact factor: 22.113

7.  Antiheparin proteins secreted by human platelets. purification, characterization, and radioimmunoassay.

Authors:  B Rucinski; S Niewiarowski; P James; D A Walz; A Z Budzynski
Journal:  Blood       Date:  1979-01       Impact factor: 22.113

8.  Non-identity of the alpha-granules of human blood platelets with typical lysosomes.

Authors:  A Siegel; E F Lüscher
Journal:  Nature       Date:  1967-08-12       Impact factor: 49.962

9.  Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.

Authors:  S Niewiarowski; C T Lowery; J Hawiger; M Millman; S Timmons
Journal:  J Lab Clin Med       Date:  1976-04

10.  An improved method for isolating alpha granules and mitochondria from human platelets.

Authors:  M J Broekman; N P Westmoreland; P Cohen
Journal:  J Cell Biol       Date:  1974-02       Impact factor: 10.539

View more
  12 in total

1.  Immunoelectron-microscopic studies of human platelet thrombospondin, von Willebrand factor, and fibrinogen redistribution during clot formation.

Authors:  S C Watkins; V Raso; H S Slayter
Journal:  Histochem J       Date:  1990-09

2.  Cleavage of protein S by a platelet membrane protease.

Authors:  C A Mitchell; H H Salem
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

3.  Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency.

Authors:  P B Tracy; A R Giles; K G Mann; L L Eide; H Hoogendoorn; G E Rivard
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

4.  Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.

Authors:  A K Sinha; A K Rao; J Willis; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

5.  Biosynthesis of factor V in isolated guinea pig megakaryocytes.

Authors:  H C Chiu; P K Schick; R W Colman
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Prothrombin is activated on vascular endothelial cells by factor Xa and calcium.

Authors:  G M Rodgers; M A Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.

Authors:  H C Chiu; E Whitaker; R W Colman
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

8.  High-molecular weight kininogen. A secreted platelet protein.

Authors:  A H Schmaier; A Zuckerberg; C Silverman; J Kuchibhotla; G P Tuszynski; R W Colman
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Activation of coagulation factor V by a platelet protease.

Authors:  W H Kane; J S Mruk; P W Majerus
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Platelet C1- inhibitor. A secreted alpha-granule protein.

Authors:  A H Schmaier; P M Smith; R W Colman
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.